版本:
中国

BRIEF-Supernus announces Q1 earnings per share $0.19

May 9 Supernus Pharmaceuticals Inc

* Supernus announces first quarter 2017 financial results

* Q1 earnings per share $0.19

* Q1 earnings per share view $0.23 -- Thomson Reuters I/B/E/S

* Supernus Pharmaceuticals -Q1 2017 product prescriptions for trokendi XR() and oxtellar XR, as reported by IMS, totaled 134,855, a 17.1% increase over Q1 of 2016

* Supernus Pharmaceuticals Inc says net product sales for Q1 of 2017 were $56.4 million, a 31.2% increase over $43.0 million in same period prior year

* Supernus Pharmaceuticals Inc sees 2017 net product sales in range of $265 million to $275 million Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐